< Back to previous page
Researcher
Joris Vermeesch
- Disciplines:Genetics, Systems biology, Medical imaging and therapy, Molecular and cell biology, Other paramedical sciences
Affiliations
- Laboratory for Cytogenetics and Genome Research (Division)
Responsible
From1 Jan 2008 → Today - Department of Human Genetics (Department)
Member
From27 Sep 2004 → Today
Infrastructure
1 - 3 of 3
- PACBIO; third -generation sequencing platform with Single Molecule Real Time technology (SMRT) (Consortium coordinator)
- EU-Genomics: EU Infrastructure for genomic analysis. (Consortium coordinator)
- Belgian Genome Biobank (Consortium coordinator)
Projects
1 - 10 of 63
- Impact of ccfDNA on clinical decision making in NEN patientsFrom8 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the functional role of the low copy repeats in the phenotypic variability of the 22q11.2 Deletion SyndromeFrom27 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Impact of ccfDNA on clinical decision making in NEN patientsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Sabbatical Joris Vermeesch: Computational analyses of large sequencing data setsFrom1 Oct 2022 → 30 Apr 2023Funding: BOF - mobility
- SymBioSys: Computationally mapping genomic heterogeneity from long read sequencing dataFrom1 Oct 2022 → TodayFunding: BOF - projects
- Implementation and validation of liquid biopsies as a diagnostic tool for early breast cancer detection in South African black womenFrom1 Sep 2022 → TodayFunding: VLIR-UOS South Initiatives
- Belgian Genome BiobankFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Remote allograft rejection diagnosis by epigenetic changes in circulating cell-free DNA in kidney transplanted patients.From1 Feb 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Mapping the role of the low copy repeats in the phenotypic variability of the 22q11 Deletion SyndromeFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 399
- Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology.(2024)
Authors: Tatjana Jatsenko, Stefania Tuveri, Lore Lannoo, Kristel Van Calsteren, Liesbeth Lenaerts, Sabine Tejpar, Bernard Thienpont, Joris Vermeesch
Pages: 2220 - Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals(2024)
Authors: Joris Vermeesch, Pascal Borry
Pages: 309 - 316 - Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age.(2024)
Authors: Ann Swillen, Jeroen Breckpot, Joris Vermeesch, Koenraad Devriendt
Pages: 368.e1 - 368.e12 - "Are we not going too far?": Socio-ethical considerations of preimplantation genetic testing using polygenic risk scores according to healthcare professionals(2024)
Authors: Maria Siermann, Joris Vermeesch, Olga Tsuiko, Pascal Borry
- Genome-wide equine preimplantation genetic testing enabled by simultaneous haplotyping and copy number detection(2024)
Authors: Olga Tsuiko, Joris Vermeesch
- WiNGS SV: A platform for analysis and federated sharing of structural variants(2024)
Authors: Joris Vermeesch
Pages: 659 - 660 - Gollop-Wolfgang Complex Is Associated with a Monoallelic Variation in WNT11(2024)
Authors: Philippe Debeer, Erika Souche, Joris Vermeesch, Przemko Tylzanowski
- Should non-invasive prenatal testing be used for fetal sex determination? Perspectives and experiences from healthcare professionals(2024)
Authors: Joris Vermeesch
Pages: 766 - 766 - Population screening for 15q11-q13 duplications: corroboration of the difference in impact between maternally and paternally inherited alleles(2024)
Authors: Koenraad Devriendt, Kris Van Den Bogaert, Joris Vermeesch
Pages: 31 - 36 - Long-read sequencing and optical genome mapping enable full characterization of previously unresolved structural variation(2024)
Authors: Joris Vermeesch
Pages: 278 - 278
Patents
1 - 8 of 8
- Method for analysing cell-free nucleic acids (Inventor)
- Method for analysing cell-free nucleic acids (Inventor)
- High-throughput genotyping by sequencing low amounts of genetic material (Inventor)
- Method for analysing cell-free nucleic acids (Inventor)
- Haplotyping and copy number typing using polymorphic variant allelic frequencies (Inventor)
- Methods for haplotyping single cells (Inventor)
- HAPLOTYPING AND COPY NUMBER TYPING USING POLYMORPHIC VARIANT ALLELIC FREQUENCIES (Inventor)
- HIGH-THROUGHPUT GENOTYPING BY SEQUENCING LOW AMOUNTS OF GENETIC MATERIAL (Inventor)